Condensed Balance Sheets - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 594,659	$ 2,329,218
Inventory	5,202,597
Prepaid expenses	328,918	759,292
Deferred financing costs		408,000
Other current assets	14,638	20,188
Total current assets	6,140,812	3,516,698
Property and equipment, net	40,976	214,578
Other assets:
Goodwill	7,647,267	7,647,267
Other non-current assets	173,010	245,683
Total assets	14,002,065	11,624,226
Current liabilities:
Accounts payable	7,009,066	3,813,280
Accrued expenses	5,066,549	3,657,394
Deferred collaboration funding, current		8,412,971
Accrued payment to collaboration partner	1,500,000
Schelling Promissory Note payable to an officer	1,016,766
Other current liabilities	743,856	741,425
Convertible note payable, current, at fair value	14,635,200
Term Loans payable, current, at fair value	18,152,344	2,326,630
Zevra bridge loan payable	13,546,557
Total current liabilities	61,670,338	18,951,700
Term Loans payable, non-current, at fair value		3,240,601
Convertible note payable, at fair value		6,047,532
Other non-current liabilities	76,689	145,665
Total liabilities	61,747,027	28,385,498
Commitments and Contingencies (Note 9)
Stockholders’ deficit:
Preferred stock, $0.0001 par value; authorized 10,000,000 shares; none issued and outstanding
Common stock, $0.0001 par value; authorized 150,000,000 shares; 24,463,726 and 19,624,280 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively	2,446	1,962
Additional paid-in capital	132,102,554	123,984,035
Accumulated deficit	(179,849,962)	(140,747,269)
Total stockholders’ deficit	(47,744,962)	(16,761,272)
Total liabilities and stockholders’ deficit	$ 14,002,065	$ 11,624,226